ACTRN12617001458325已完成2 期
An Open-Label Study of the Safety and Tolerability of AeroFactTM (Aerosolized Alveofact®) in Preterm Infants on nCPAP at Risk for Worsening Respiratory Distress Syndrome.
CPR Pharma Services0 个研究点目标入组 30 人开始时间: 2017年10月16日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- Hours 至 2 Hours（—）
- 性别
- All
入选标准
- •Preterm infants born at 26 0/7 to 29 6/7 weeks gestational age, with weight appropriate for age, who are on nCPAP, and a FiO2 less than 0.30.
排除标准
- •Preterm infants who required mechanical ventilation and prior instillation of surfactant; significant congenital anomaly; other diseases that might interfere with cardiopulmonary functions; known or suspected chromosomal abnormality; concomitant treatment with inhaled nitric oxide.
研究者
相似试验
进行中（未招募）
1 期
An Open-Label Study Of The Safety And Tolerability Of Memantine InPediatric Patients With Autism, Asperger’s Disorder, Or PervasiveDevelopmental Disorder Not Otherwise Specified (PDD-NOS)Autism or Asperger’s Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)MedDRA version: 16.0Level: LLTClassification code 10008520Term: Childhood autismSystem Organ Class: 100000004852MedDRA version: 16.0Level: PTClassification code 10003484Term: Asperger's disorderSystem Organ Class: 10037175 - Psychiatric disordersMedDRA version: 16.0Level: LLTClassification code 10034739Term: Pervasive developmental disorder NOSSystem Organ Class: 10037175 - Psychiatric disordersEUCTR2012-001616-33-BEForest Research Institute, Inc.900
进行中（未招募）
不适用
An Open-Label Study Of The Safety And Tolerability Of Memantine InPediatric Patients With Autism, Asperger’s Disorder, Or PervasiveDevelopmental Disorder Not Otherwise Specified (PDD-NOS)Autism or Asperger’s Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)MedDRA version: 14.1Level: LLTClassification code 10008520Term: Childhood autismSystem Organ Class: 100000004852MedDRA version: 14.1Level: PTClassification code 10003484Term: Asperger's disorderSystem Organ Class: 10037175 - Psychiatric disordersMedDRA version: 14.1Level: LLTClassification code 10034739Term: Pervasive developmental disorder NOSSystem Organ Class: 10037175 - Psychiatric disordersEUCTR2012-001616-33-EEForest Research Institute, Inc.900
进行中（未招募）
不适用
An Open-Label Study Of The Safety And Tolerability Of Memantine InPediatric Patients With Autism, Asperger’s Disorder, Or PervasiveDevelopmental Disorder Not Otherwise Specified (PDD-NOS)EUCTR2012-001616-33-ISForest Research Institute, Inc.192
进行中（未招募）
1 期
An Open-Label Study Of The Safety And Tolerability Of Memantine InPediatric Patients With Autism, Asperger?s Disorder, Or PervasiveDevelopmental Disorder Not Otherwise Specified (PDD-NOS)Autism or Asperger?s Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)MedDRA version: 14.1Level: LLTClassification code 10008520Term: Childhood autismSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 14.1Level: PTClassification code 10003484Term: Asperger's disorderSystem Organ Class: 10037175 - Psychiatric disordersMedDRA version: 14.1Level: LLTClassification code 10034739Term: Pervasive developmental disorder NOSSystem Organ Class: 10037175 - Psychiatric disordersEUCTR2012-001616-33-ESForest Research Institute, Inc.906
进行中（未招募）
不适用
An Open-Label Study Of The Safety And Tolerability Of Memantine InPediatric Patients With Autism, Asperger’s Disorder, Or PervasiveDevelopmental Disorder Not Otherwise Specified (PDD-NOS)EUCTR2012-001616-33-HUForest Research Institute, Inc.900